Current Investments
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
Ra Pharmaceuticals, Inc.
Doug Treco, Cambridge, MA, US
Ra Pharmaceuticals is developing a novel class of orally bioavailable biologic drugs designed to modulate an array of intracellular,cell surface, and circulating proteins.